CooperCompanies to Present at Oppenheimer’s 33rd Annual Healthcare Conference

Rhea-AI Summary

CooperCompanies (NYSE: COO) will participate in Oppenheimer’s 33rd Annual Healthcare Conference on March 14, 2022, with a virtual session starting at 2:40 PM ET. The event will be represented by Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer.

Investors can access the webcast on the CooperCompanies’ website, with a replay available post-event. Cooper operates through two primary business units: CooperVision and CooperSurgical, focusing on vision care and women's health, respectively. The company is headquartered in San Ramon, CA, employs over 14,000 individuals, and sells products in over 100 countries.

SAN RAMON, Calif., Feb. 15, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in Oppenheimer’s 33^rd Annual Healthcare Conference on Tuesday, March 14, 2022. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a virtual session scheduled to begin at 2:40 PM ET.

The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. A replay of the event will be available on the same webpage following its conclusion.

About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 14,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.

Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com

FAQ

What is the date of CooperCompanies' participation in the Oppenheimer Conference?

CooperCompanies will participate in the Oppenheimer’s 33rd Annual Healthcare Conference on March 14, 2022.

Who will represent CooperCompanies at the conference?

Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent CooperCompanies.

What time is CooperCompanies' virtual session scheduled for?

The virtual session is scheduled to begin at 2:40 PM ET.

Where can I access the webcast of the CooperCompanies conference session?

The webcast can be accessed on the CooperCompanies’ website at investor.coopercos.com.

Will there be a replay available for the CooperCompanies conference session?

Yes, a replay of the event will be available on the same webpage following its conclusion.